After obtaining informed consent, genomic DNA was extracted from leukocytes. First, we amplified the region containing the trinucleotide repeats in ATXN2 using the primer pair SCA2-A (59-GGGCCCCTCACCATGTCG-39) and SCA2-B (59-CGGGCTTGCGGACATTGG-39) and found a single amplicon slightly larger than a normal 22 trinucleotide repeat length (figure, C). Other genes for SCAs, including SCA1, 3, and 6, and DRPLA were normal (data not shown). Next, Sanger sequencing for the ATXN2 repeat region was performed, which demonstrated homozygous (CAG) 13 CAA(CAG) 8 CAA(CAG) 8 , a total of 31 trinucleotide repeats, and a chromatogram without overlap by another repeat length ( figure, D) . Finally, we applied whole exome sequencing to exclude other genetic causes of ataxia (table e-1, links.lww.com/ NXG/A111) and found no causative mutation among the candidate genes except the homozygous expansion of trinucleotide repeats in ATXN2 (e-methods, links.lww.com/NXG/A114 and table e-2, links.lww.com/NXG/A112).
Discussion
Polyglutamine (polyQ) diseases are neurodegenerative disorders caused by the expansion of a trinucleotide (CAG) repeat, which is translated into an abnormally elongated glutamine (Q) tract in the respective mutant proteins. There are 9 known polyQ diseases, including 6 different spinocerebellar ataxias (SCA1, 2, 3, 6, 7, 17), dentatorubralpallidoluysian atrophy, Huntington's disease, and spinal and bulbar muscular atrophy. All except for SBMA are inherited in an autosomal dominant manner, and each has its own normal, intermediate, and expanded trinucleotide repeat sizes. While there are several reports of cases homozygous for expanded trinucleotide repeat size, cases homozygous for intermediate trinucleotide repeat size are rare. 5 Furthermore, there is no report of a homozygous normal trinucleotide repeat as causative of disease.
The present clinical findings were consistent with early stage SCA2, and laboratory and gene analysis results ruled out other diseases presenting cerebellar ataxia. Although parental consanguinity of this index case is not clear, the parents may share a common ancestor for 2 reasons: one is that both originated from an isolated area of Okayama Prefecture in Japan, and the other is that the genomic region containing ATXN2 was a homozygous segment suggesting autozygosity (table e-3, links.lww.com/NXG/A113). The sister of the patient with ALS may reflect the association of an intermediate expansion of the trinucleotide repeat in ATXN2 and ALS. 6 As for the trinucleotide repeat length in ATXN2, 33 repeats are pathogenic (i.e., fully penetrant) and 32 in a homozygous state have been associated with very late-onset cerebellar ataxia, although clinical information has not been published. 6 Cerebellar ataxia is never caused by 31 repeats in a heterozygous state. Therefore, the present case is important because it shows that a 31 trinucleotide repeat length in ATXN2 in a homozygous state is pathogenic. A pathogenic effect of a homozygous intermediate trinucleotide repeat in SCA6, another polyQ disease, has been demonstrated. 5 Taken together, in polyQ disease, an intermediate trinucleotide repeat length in a homozygous state has the potential to cause disease because of a gene dosage effect, although the repeat is not necessarily pathogenic in a heterozygous state. One available mechanism-based treatment for patients with polyQ disease is reducing the levels of toxic disease-gene products by antisense oligonucleotides, short hairpin RNAs, or miRNAs. 7 The present case suggests that in polyQ diseases with an intermediate to hopefully mildly expanded trinucleotide repeat length, the reduction of polyQ proteins by ;50% should substantially mitigate the effects of the disease.
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